Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth.

Neurofibromatosis type-1 (NF1) patients suffer from cutaneous and subcutaneous neurofibromas (CNF) and large plexiform neurofibromas (PNF). Whole gene deletions of the NF1 gene can cause a more severe phenotype compared to smaller intragenic changes. Two distinct groups of NF1 whole gene deletions a...

Full description

Saved in:
Bibliographic Details
Main Authors: Lennart Well, Kimberly Döbel, Lan Kluwe, Peter Bannas, Said Farschtschi, Gerhard Adam, Victor-Felix Mautner, Johannes Salamon
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-05-01
Series:PLoS Genetics
Online Access:https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1009517&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850181857157578752
author Lennart Well
Kimberly Döbel
Lan Kluwe
Peter Bannas
Said Farschtschi
Gerhard Adam
Victor-Felix Mautner
Johannes Salamon
author_facet Lennart Well
Kimberly Döbel
Lan Kluwe
Peter Bannas
Said Farschtschi
Gerhard Adam
Victor-Felix Mautner
Johannes Salamon
author_sort Lennart Well
collection DOAJ
description Neurofibromatosis type-1 (NF1) patients suffer from cutaneous and subcutaneous neurofibromas (CNF) and large plexiform neurofibromas (PNF). Whole gene deletions of the NF1 gene can cause a more severe phenotype compared to smaller intragenic changes. Two distinct groups of NF1 whole gene deletions are type-1 deletions and atypical deletions. Our aim was to assess volumes and averaged annual growth-rates of CNF and PNF in patients with NF1 whole gene deletions and to compare these with NF1 patients without large deletions of the NF1 gene. We retrospectively evaluated 140 whole-body MR examinations of 38 patients with NF1 whole gene deletions (type-1 group: n = 27/atypical group n = 11) and an age- and sex matched collective of 38 NF1-patients. Age-dependent subgroups were created (0-18 vs >18 years). Sixty-four patients received follow-up MRI examinations (NF1whole gene deletion n = 32/control group n = 32). Whole-body tumor-volumes were semi-automatically assessed (MedX, V3.42). Tumor volumes and averaged annual growth-rates were compared. Median tumor-burden was significantly higher in the type-1 group (418ml; IQR 77 - 950ml, p = 0.012) but not in the atypical group (356ml;IQR 140-1190ml, p = 0.099) when compared to the controls (49ml; IQR 11-691ml). Averaged annual growth rates were significantly higher in both the type-1 group (14%/year; IQR 45-36%/year, p = 0.004) and atypical group (11%/year; IQR 5-23%/year, p = 0.014) compared to the controls (4%/year; IQR1-8%/year). Averaged annual growth rates were significantly higher in pediatric patients with type-1 deletions (21%/year) compared with adult patients (8%/year, p = 0.014) and also compared with pediatric patients without large deletions of the NF1 gene (3.3%/year, p = 0.0015). NF1 whole gene deletions cause a more severe phenotype of NF1 with higher tumor burden and higher growth-rates compared to NF1 patients without large deletions of the NF1 gene. In particular, pediatric patients with type-1 deletions display a pronounced tumor growth.
format Article
id doaj-art-1083c83b07bd4ff4ad4e57786921add6
institution OA Journals
issn 1553-7390
1553-7404
language English
publishDate 2021-05-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Genetics
spelling doaj-art-1083c83b07bd4ff4ad4e57786921add62025-08-20T02:17:49ZengPublic Library of Science (PLoS)PLoS Genetics1553-73901553-74042021-05-01175e100951710.1371/journal.pgen.1009517Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth.Lennart WellKimberly DöbelLan KluwePeter BannasSaid FarschtschiGerhard AdamVictor-Felix MautnerJohannes SalamonNeurofibromatosis type-1 (NF1) patients suffer from cutaneous and subcutaneous neurofibromas (CNF) and large plexiform neurofibromas (PNF). Whole gene deletions of the NF1 gene can cause a more severe phenotype compared to smaller intragenic changes. Two distinct groups of NF1 whole gene deletions are type-1 deletions and atypical deletions. Our aim was to assess volumes and averaged annual growth-rates of CNF and PNF in patients with NF1 whole gene deletions and to compare these with NF1 patients without large deletions of the NF1 gene. We retrospectively evaluated 140 whole-body MR examinations of 38 patients with NF1 whole gene deletions (type-1 group: n = 27/atypical group n = 11) and an age- and sex matched collective of 38 NF1-patients. Age-dependent subgroups were created (0-18 vs >18 years). Sixty-four patients received follow-up MRI examinations (NF1whole gene deletion n = 32/control group n = 32). Whole-body tumor-volumes were semi-automatically assessed (MedX, V3.42). Tumor volumes and averaged annual growth-rates were compared. Median tumor-burden was significantly higher in the type-1 group (418ml; IQR 77 - 950ml, p = 0.012) but not in the atypical group (356ml;IQR 140-1190ml, p = 0.099) when compared to the controls (49ml; IQR 11-691ml). Averaged annual growth rates were significantly higher in both the type-1 group (14%/year; IQR 45-36%/year, p = 0.004) and atypical group (11%/year; IQR 5-23%/year, p = 0.014) compared to the controls (4%/year; IQR1-8%/year). Averaged annual growth rates were significantly higher in pediatric patients with type-1 deletions (21%/year) compared with adult patients (8%/year, p = 0.014) and also compared with pediatric patients without large deletions of the NF1 gene (3.3%/year, p = 0.0015). NF1 whole gene deletions cause a more severe phenotype of NF1 with higher tumor burden and higher growth-rates compared to NF1 patients without large deletions of the NF1 gene. In particular, pediatric patients with type-1 deletions display a pronounced tumor growth.https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1009517&type=printable
spellingShingle Lennart Well
Kimberly Döbel
Lan Kluwe
Peter Bannas
Said Farschtschi
Gerhard Adam
Victor-Felix Mautner
Johannes Salamon
Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth.
PLoS Genetics
title Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth.
title_full Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth.
title_fullStr Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth.
title_full_unstemmed Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth.
title_short Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth.
title_sort genotype phenotype correlation in neurofibromatosis type 1 nf1 whole gene deletions lead to high tumor burden and increased tumor growth
url https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1009517&type=printable
work_keys_str_mv AT lennartwell genotypephenotypecorrelationinneurofibromatosistype1nf1wholegenedeletionsleadtohightumorburdenandincreasedtumorgrowth
AT kimberlydobel genotypephenotypecorrelationinneurofibromatosistype1nf1wholegenedeletionsleadtohightumorburdenandincreasedtumorgrowth
AT lankluwe genotypephenotypecorrelationinneurofibromatosistype1nf1wholegenedeletionsleadtohightumorburdenandincreasedtumorgrowth
AT peterbannas genotypephenotypecorrelationinneurofibromatosistype1nf1wholegenedeletionsleadtohightumorburdenandincreasedtumorgrowth
AT saidfarschtschi genotypephenotypecorrelationinneurofibromatosistype1nf1wholegenedeletionsleadtohightumorburdenandincreasedtumorgrowth
AT gerhardadam genotypephenotypecorrelationinneurofibromatosistype1nf1wholegenedeletionsleadtohightumorburdenandincreasedtumorgrowth
AT victorfelixmautner genotypephenotypecorrelationinneurofibromatosistype1nf1wholegenedeletionsleadtohightumorburdenandincreasedtumorgrowth
AT johannessalamon genotypephenotypecorrelationinneurofibromatosistype1nf1wholegenedeletionsleadtohightumorburdenandincreasedtumorgrowth